The Study of Different Cycles of High-dose Dexamethasone in the Treatment of ITP

Summary

Primary immune thrombocytopenia is an autoimmune disorder characterised by decreased platelet counts and increased bleeding risk. Corticosteroids have been the standard initial treatment of primary immune thrombocytopenia for more than 30 years. The aim of this randomized controlled trial is to compare the efficacy and safety of high-dose dexamethasone in treating new-diagnosed primary immune thrombocytopenia (ITP) in di-cycle and tri-cycle.

Timeline

Start

2025-05-01

Primary completion

2026-05-30

Completion

2027-05-30

Drugs

Indications